AU2003211610A1 - Pharmaceutical compositions for the treatment or prevention of osteoporosis - Google Patents

Pharmaceutical compositions for the treatment or prevention of osteoporosis

Info

Publication number
AU2003211610A1
AU2003211610A1 AU2003211610A AU2003211610A AU2003211610A1 AU 2003211610 A1 AU2003211610 A1 AU 2003211610A1 AU 2003211610 A AU2003211610 A AU 2003211610A AU 2003211610 A AU2003211610 A AU 2003211610A AU 2003211610 A1 AU2003211610 A1 AU 2003211610A1
Authority
AU
Australia
Prior art keywords
osteoporosis
prevention
treatment
pharmaceutical compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003211610A
Other languages
English (en)
Inventor
Alvaro Acebron Fernandez
Dolores Blanco Lousame
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SA
Original Assignee
Italfarmaco SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco SA filed Critical Italfarmaco SA
Publication of AU2003211610A1 publication Critical patent/AU2003211610A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003211610A 2002-01-04 2003-01-03 Pharmaceutical compositions for the treatment or prevention of osteoporosis Abandoned AU2003211610A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200200017A ES2192136B1 (es) 2002-01-04 2002-01-04 Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
ESP200200017 2002-01-04
PCT/ES2003/000002 WO2003055500A1 (es) 2002-01-04 2003-01-03 Composiciones farmaceuticas para tratamiento o prevencion de la osteoporosis

Publications (1)

Publication Number Publication Date
AU2003211610A1 true AU2003211610A1 (en) 2003-07-15

Family

ID=8500130

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003211610A Abandoned AU2003211610A1 (en) 2002-01-04 2003-01-03 Pharmaceutical compositions for the treatment or prevention of osteoporosis

Country Status (3)

Country Link
AU (1) AU2003211610A1 (es)
ES (1) ES2192136B1 (es)
WO (1) WO2003055500A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI20030194A1 (it) * 2003-07-17 2005-01-18 Menarini Int Operations Lu Sa Composizione farmaceutiche effervescenti contenenti
KR100898970B1 (ko) 2004-05-24 2009-05-25 니코메드 파마 에이에스 칼슘-함유 화합물 및 당알코올을 포함하는 입상체
CN1997362B (zh) * 2004-06-01 2010-09-08 奈科明制药有限公司 包括含钙化合物作为活性物质的可咀嚼、可吮吸和可吞咽片剂
ES2255429B1 (es) * 2004-10-25 2007-08-16 Italfarmaco, S.A. Composiciones farmaceuticas bucodispersables.
CN103479582A (zh) 2005-02-03 2014-01-01 武田奈科明有限公司 制备含钙组合物的快速湿聚结方法
EP1845949B1 (en) 2005-02-03 2008-05-21 Nycomed Pharma AS Melt granulation of a composition containing a calcium-containing compound
CN101365426B (zh) 2005-12-07 2012-08-08 奈科明制药有限公司 预先压实的含钙组合物
US7968130B2 (en) 2006-01-11 2011-06-28 Mission Pharmacal Co. Calcium-enriched food product
MX2011004744A (es) 2008-11-17 2011-05-30 Nycomed Pharma As Estabilidad mejorada de disolucion de tabletas de carbonato de calcio.
WO2019004984A2 (en) * 2017-05-29 2019-01-03 Biofarma Ilac Sanayi Ve Ticaret A.S. PHARMACEUTICAL FORMULATION COMPRISING CHOLECALCIFEROL
CN109288811B (zh) * 2018-11-27 2021-02-09 正大制药（青岛）有限公司 一种艾地骨化醇软胶囊及其制备方法
CN109568279B (zh) * 2018-12-28 2020-10-20 正大制药（青岛）有限公司 一种氟骨化醇片剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345265A (en) * 1963-10-09 1967-10-03 Kendall & Co Multiple layer tablet with calcium salt central core separated from soluble fluoride outer coating
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
US5013728A (en) * 1990-05-04 1991-05-07 Colgate - Palmolive Company Composition for treating osteoporosis and hormonal imbalance
US5228445A (en) * 1990-06-18 1993-07-20 Board Of Regents, The University Of Texas System Demonstration by in vivo measurement of reflection ultrasound analysis of improved bone quality following slow-release fluoride treatment in osteoporosis patients
AU7295696A (en) * 1995-10-27 1997-05-22 F. Hoffmann-La Roche Ag Pharmaceutical composition for treating osteoporosis
CN1177455A (zh) * 1996-09-26 1998-04-01 天津市红桥医院 加碘低钠钙盐
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
CA2308532C (en) * 1999-05-12 2005-11-29 Gador S.A. Use of bisphosphonates for the treatment of osteogenesis imperfecta
US20020041902A1 (en) * 2000-09-29 2002-04-11 Steiner Gregory Gene Fluoride as a chemoprotective and chemotheraputic agent for cancer in mammals

Also Published As

Publication number Publication date
ES2192136B1 (es) 2005-03-16
WO2003055500A1 (es) 2003-07-10
WO2003055500A8 (es) 2004-04-29
ES2192136A1 (es) 2003-09-16

Similar Documents

Publication Publication Date Title
AU2003205226A1 (en) Compositions for treatment or prevention of bioterrorism
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
HK1080409A1 (en) Bisphosphonic acid for the treatment and prevention of osteoporosis
AU2003274342A1 (en) Compositions for the treatment of autoimmune disorders
IL164896A (en) Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors
AU2003245504A1 (en) Pharmaceutical compositions for drugs having ph-dependentsolubility
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2003263760A1 (en) Methods for the treatment or prevention of obesity
AU2002323823A1 (en) Medicament for prevention and treatment of fracture and osteoporosis
AU2003211610A1 (en) Pharmaceutical compositions for the treatment or prevention of osteoporosis
HU0302441D0 (en) Pharmaceutical compositions having antibiothic effect
AU2003222352A1 (en) Compositions for the treatment of magnesium alloys
HUP0303779D0 (en) Pharmaceutical compositions for the treatment of sclerosis multiplex
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
AU2003211540A1 (en) Medicinal compositions for inhibiting tryptase
AU2003251362A1 (en) Compositions formed from the reduction of lanolin
EP1809599B8 (en) Vitamin d3 analogues for the prevention and treatment of bone disorders
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
AU2002359034A1 (en) Process for the preparation of simvastatin
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
HUP0200253A3 (en) Pharmaceutical compositions for combination therapy
AU2002251202A1 (en) Intimins for the prevention or treatment of infections: i
MXPA03006468A (es) Composiciones para la prevencion o tratamiento de hepatopatia.
AU2002308881A1 (en) Pharmaceutical composition for prevention or treatment of arthritis
AU2002226682A1 (en) Compositions for prevention or treatment of hepatopathy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase